Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

$OGI
Biotechnology: Pharmaceutical Preparations
Health Care
Get the next $OGI alert in real time by email

Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram Global"), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will gain valuable insights into the Company's growth trajectory, engage directly with leadership on key industry trends, and get a behind-the-scenes look at the innovation and strategy driving Organigram Global forward.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250402121386/en/

Register here to get exclusive access to this event on April 10 at 4pm EST via Zoom. Event access details will be shared upon registering.

"We're excited to host our first-ever virtual investor event as a way to connect directly with our shareholders and the broader investment community," said Beena Goldenberg, CEO of Organigram Global. "This is more than just a look at where we are today—it's about sharing where we're headed. From our strategic vision and financial performance to the innovation fueling our growth, attendees will gain a well-rounded understanding of what sets Organigram Global apart and how we're building for the future."

Hear directly from the leaders shaping Organigram Global's success:

  • Beena Goldenberg – CEO, on the vision and market strategy
  • Greg Guyatt – CFO, on financial performance and growth trajectory
  • Borna Zlamalik – SVP of R&D and Innovation, on innovation
  • Hosted by Max Schwartz, Director of Investor Relations

Attendees will also have exclusive access to behind-the-scenes video tours of Organigram Global's various facilities, along with the opportunity to engage directly with senior management during a live Q&A.

Trading on TSX/NASDAQ

Further to the Company's news release dated March 26, 2025, the Toronto Stock Exchange ("TSX") has approved the name change to "Organigram Global Inc.".

The Company's common shares will begin trading on TSX and NASDAQ effective at the opening of trading today under the new name and the current stock symbol "OGI". As part of the name change, the common shares of the Company have been assigned new CUSIP 68617J100 and ISIN CA68617J1003 numbers, and the warrants of the Company have been assigned new CUSIP 68617J118 and ISIN CA68617J1185 numbers.

Organigram Global recently launched its new identity, visit the newly launched www.organigram.ca to know more.

About Organigram

Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor . Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets. the US and Canadian cannabinoid beverages markets.

Organigram Global is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram Global has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, DEBUNK and Collective Project. Organigram Global operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Forward-Looking Information

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words and phrases or state that certain actions, events, or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information including expectations regarding market performance, involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram Global to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis, and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

For Media enquiries:

Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs megan.mccrae@organigram.ca

For Investor Relations enquiries:

Max Schwartz, Director of Investor Relations

investors@organigram.ca

Get the next $OGI alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OGI

DatePrice TargetRatingAnalyst
7/17/2024Speculative Buy
Canaccord Genuity
4/15/2024Neutral → Buy
Alliance Global Partners
1/13/2023Hold → Buy
Stifel
1/12/2022Hold → Speculative Buy
Canaccord Genuity
1/12/2022$5.70 → $5.30Overweight
Cantor Fitzgerald
12/8/2021$5.50 → $5.70Overweight
Cantor Fitzgerald
More analyst ratings

$OGI
Press Releases

Fastest customizable press release news feed in the world

See more
  • Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram Global"), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will gain valuable insights into the Company's growth trajectory, engage directly with leadership on key industry trends, and get a behind-the-scenes look at the innovation and strategy driving Organigram Global forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250402

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Organigram Enters U.S. Through Acquisition of Collective Project Beverages

    Acquisition Marks Commercial Market Entry in the Fast-Growing Hemp-Derived THC Beverage Category in the U.S. and the Emerging Canadian Cannabis Beverage Category Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Collective Project Limited ("CPL") for upfront consideration of approximately C$6.2 million, potential milestone payments and potential earnout payments totaling in the aggregate up to C$24M for the twelve-month periods ending September 30, 2025 and September 30, 2026. This press release features multimedia. View the full

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence

    Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is proud to announce its official rebrand to Organigram Global Inc. ("Organigram Global"), a move that demonstrates the Company's evolution from an East Coast medical cannabis company into a burgeoning global cannabis leader. Having achieved the number one position in market share in Canada1 and established a growing international footprint, Organigram Global is now focused on accelerating its global expansion and strengthening its presence in key international markets. With strategic international investments and expanding export partnerships, the Company is focused o

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

$OGI
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$OGI
SEC Filings

See more

$OGI
Leadership Updates

Live Leadership Updates

See more
  • Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.

    Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI) announced today the results of voting at its annual general and special meeting of shareholders (the "Shareholders") held virtually on March 24, 2025 (the "Meeting"). Shareholder Approval of the Name Change and Articles of Amendment At the Meeting, a special resolution approving an amendment to the articles of the Company to change the name of the Company to "Organigram Global Inc." (the "Name Change"), was approved by the affirmative vote of 95.778% of the votes represented at the Meeting. The Name Change remains subject to regulatory approvals, including the approval of the TSX. The TSX has conditionally ap

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Organigram Announces Appointment of Craig Harris to Board of Directors

    Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced the appointment of Craig Harris to the Organigram Board of Directors effective today. Craig brings over 20 years of experience as a commercial lawyer, with a background in private practice and legal and regulatory engagement roles for various corporations. He is currently the Assistant General Counsel – Corporate & Commercial Legal at British American Tobacco plc (BAT). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240729497569/en/Craig Harris (Photo: Business Wire) "We are thrilled to welcome Cra

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Organigram Announces Appointment of Karina Gehring to Board of Directors

    Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company's annual general and special meeting held on January 18, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240119151071/en/Karina Gehring (Photo: Business Wire) "We are thrilled to welcome Karina to our Board of Directors. Her extensive expertise in marketing and brand management combined with her ongoing experience with BAT will be a tremendous asset to our Board," said Peter Amirault, Board Chair, Organigram. Karina is one of two directors (includi

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

$OGI
Financials

Live finance-specific insights

See more
  • Organigram Enters U.S. Through Acquisition of Collective Project Beverages

    Acquisition Marks Commercial Market Entry in the Fast-Growing Hemp-Derived THC Beverage Category in the U.S. and the Emerging Canadian Cannabis Beverage Category Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Collective Project Limited ("CPL") for upfront consideration of approximately C$6.2 million, potential milestone payments and potential earnout payments totaling in the aggregate up to C$24M for the twelve-month periods ending September 30, 2025 and September 30, 2026. This press release features multimedia. View the full

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Organigram Reports First Quarter Fiscal 2025 Results

    17% growth in net revenue to $42.7 million year-over-year $2.3 million growth in international sales year-over-year Adjusted EBITDA1 of $1.4 million versus $0.1 million in the prior year period Completed acquisition of Motif to become recreational cannabis market leader in Canada Launched Edison Sonics with proprietary FAST™ nanoemulsion technology, clinically validated to have up to 50% faster onset and nearly 2x impact of cannabinoids at peak Strong balance sheet with negligible debt, and a pro-forma cash position of $113 million2 Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its resu

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025

    Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2025 ended December 31, 2024, on Tuesday, February 11, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 11, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I967665 To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 min

    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

$OGI
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more